APOE-mediated sex differences in microvascular pathology and AD-associated proteinopathies in the medial temporal

Francesco Bax1,2, Jan Oltmer3, Corinne A Auger4,5

  • 1J. Philip Kistler Stroke Research Center, Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.

Abstract

Insights

Sex influences Alzheimer's disease (AD) pathologies in the medial temporal lobe. Women with cerebral amyloid angiopathy (CAA) had less amyloid beta (Aβ) but more tau tangles, highlighting sex-specific AD progression.

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases
  • Vascular Dementia

Background:

  • Cerebral small vessel disease (CSVD) is a known contributor to Alzheimer's disease (AD) dementia.
  • CSVD often co-occurs with AD-associated proteinopathies.
  • The modulating role of sex in the interaction between CSVD and AD pathologies in the medial temporal lobe (MTL) is not well understood.

Purpose of the Study:

  • To investigate the effect of sex on AD-associated proteinopathies.
  • To analyze the interaction between sex, CSVD, and apolipoprotein E (APOE) genotype in the MTL.

Main Methods:

  • Analysis of 152 autopsy cases from the Massachusetts Alzheimer's Disease Research Center.
  • Application of deep-learning and semiquantitative scores to MTL histological sections.
  • Quantitative measurement of proteinopathies and CSVD (cerebral amyloid angiopathy [CAA] and arteriolosclerosis).
  • Linear mixed-effect models used to analyze the effects of sex, CSVD, and APOE genotype.

Main Results:

  • In women, increased CAA burden correlated with decreased amyloid beta (Aβ) plaques but increased tau tangles density.
  • Arteriolosclerosis showed no interaction effect with sex.
  • Younger women (<75 years) with the APOE ε4 allele had a higher Aβ plaque burden compared to non-carriers.

Conclusions:

  • Sex exerts a complex influence on the interplay between microvascular disease and AD-associated pathologies in the MTL.
  • Findings suggest sex-specific mechanisms in AD pathogenesis involving vascular and proteinopathy interactions.